Expression of cell cycle regulators p57KIP2, cyclin D1, and cyclin E in epithelial ovarian tumors and survival
- 1 August 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (8), 808-813
- https://doi.org/10.1053/hupa.2001.26462
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-Term Results and Prognostic Factors in Patients with Epithelial Ovarian CancerGynecologic Oncology, 2000
- Regulation of the Cdk inhibitor p27 and its deregulation in cancerJournal of Cellular Physiology, 2000
- Expression of the Cell Cycle Inhibitor p27KIP1 Is a New Prognostic Marker Associated with Survival in Epithelial Ovarian TumorsThe American Journal of Pathology, 1999
- Expression of Cyclin E in Gynecologic MalignanciesGynecologic Oncology, 1999
- Oncogene Expression: Long-Term Compared With Short-Term Survival in Patients With Advanced Epithelial Ovarian CancerObstetrics & Gynecology, 1998
- Analysis of cyclin E and CDK2 in ovarian cancer: Gene amplification and RNA overexpressionInternational Journal of Cancer, 1998
- Altered expression of cyclin D1 andCDK4 genes in ovarian carcinomasInternational Journal of Cancer, 1997
- Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndromeNature, 1997
- Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumorsHuman Pathology, 1996
- Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.Genes & Development, 1995